Jeffery S. Weber at Cancer Crosslinks. Photo: Oslo Cancer Cluster.

10th Cancer Crosslinks: Precision Treatment Reviewed

For the tenth time the cancer experts gathered to share knowledge and ideas at Oslo Cancer Cluster Innovation Park. Last week it was time for this year’s Cancer Crosslinks and the day covered themes from immunology to Big Data.   Cancer research is changing rapidly.  Immunotherapy and precision medicine has revolutionized cancer treatment. This year’s […]

Follow the 10th Cancer Crosslinks: Stream and Program

Thursday January the 18th it’s time for the 10th Cancer Crosslinks here at Oslo Cancer Cluster Innovation Park. Hospital personnel, researchers and everybody interested get together for an update on – and to discuss – the latest within cancer research.   This year’s conference will focus on Precision Treatment in cancer research with the headline: […]

From the left: Director of Finance at Apotekforeningen Helge Ranvik, Chairman at Curida Per S. Thoresen, Director of Finance at Curida Terje Gabrielsen, CEO of Curida Leif Rune Skymoen, CEO of Ås produksjonslab Gro Noraker and CEO of Apotekforeningen Per T. Lund.

Curida Takover Secures Norwegian Production

To secure Norwegian pharmaceutical production, Oslo Cancer Cluster- member Curida has completed a takeover of Ås produksjonslab AS.   Continued Production at Ås Curida operate in an international marketplace and here the last line of production of pharmaceuticals is mostly taken care of by specialized operators. «Ås produksjonslab» is a company rich in tradition, it […]

Fremtidens kreftbehandling – ta med egne data!

Les kronikken, fra 21.12. 2017 i Aftenposten, om hvordan vi bør forme våre nye sykehusbygg av Ketil Widerberg. Den nye klinikken på Radiumhospitalet må ta helsedatarevolusjonen på alvor. Radiumhospitalet ved Oslo universitetssykehus får nytt klinikkbygg. En god nyhet for kreftpasienter, som blir enda bedre hvis pasientene selv får bidra med data om egen helse. Et […]

Breakthrough Agreement for Phoenix Solutions

A new exciting collaboration among two Oslo Cancer Cluster members has been initiated. GE Healthcare has agreed to be the manufacturer of the target drug delivery platform ACT, made by Phoenix Solutions. Early Christmas Present As an early Christmas present to each other the two companies announced that they had signed an agreement securing manufacturing […]

Chairman Roy H. Larsen proudly presents the new lab to interested visitors. Image: Oncoinvent.

Oncoinvent With New Lab and Bright Future

The cancer research company and Oslo Cancer Cluster-member Oncoinvent opened this Thursday a brand-new lab and research facilities at Nydalen Oslo. Now they control the whole production line and continue their development of their lead product candidate Radspherin. A Good Year 2017 has been a good year for Oncoinvent. The company has now relocated and […]